Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Amarin Corp ADR (NQ: AMRN )

1.210 +0.040 (+3.42%)
Streaming Delayed Price Updated: 4:00 PM EDT, Jun 1, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 3,019,584
Open 1.210
Bid (Size) 1.200 (7)
Ask (Size) 1.220 (8)
Prev. Close 1.170
Today's Range 1.165 - 1.270
52wk Range 1.040 - 2.230
Shares Outstanding 407,265,944
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Amarin to Present at Two Upcoming Investor Conferences
From Amarin Corporation plc
Via GlobeNewswire
Amarin Partner EddingPharm Receives Regulatory Approval for Vascepa® (Icosapent Ethyl) in Mainland China
From Amarin Corporation plc
Via GlobeNewswire

Performance

YTD
+1.68%
+1.68%
1 Month
-14.18%
-14.18%
3 Month
-37.95%
-37.95%
6 Month
+1.68%
+1.68%
1 Year
-16.55%
-16.55%

More News

Read More
3 Biotech Stocks to Avoid Like the Plague
Via InvestorPlace
Amarin Highlights New Data Providing Potential Mechanistic Insight into Vascepa®/Vazkepa® (Icosapent Ethyl) Reduction of Cardiovascular Events
From Amarin Corporation plc
Via GlobeNewswire
Amarin Corp's Return On Capital Employed Insights
Via Benzinga
Amarin Plc (AMRN) Q1 2023 Earnings Call Transcript
Via The Motley Fool
Recap: Amarin Corp Q1 Earnings
Via Benzinga
Amarin Reports Stable Revenue, Cash Position In Q1 But Lowers FY23 Operating Expense Guidance: What's Next?
Via Benzinga
Amarin Reports First Quarter 2023 Financial Results and Provides Business Update
From Amarin Corporation plc
Via GlobeNewswire
Amarin to Report First Quarter 2023 Financial Results and Host Conference Call on May 3, 2023
From Amarin Corporation plc
Via GlobeNewswire
Amarin Names Aaron Berg Interim President & Chief Executive Officer and Adds Oliver O’Connor to Company’s Board of Directors
From Amarin Corporation plc
Via GlobeNewswire
Amarin Plc (AMRN) Q4 2022 Earnings Call Transcript
Via The Motley Fool
Earnings Scheduled For March 1, 2023
Via Benzinga
Why Agenus, Amarin, and Axsome Therapeutics Shares Slumped Today
Via The Motley Fool
Amarin Announces VAZKEPA® (Icosapent Ethyl) Approved by Israel's Ministry of Health
From Amarin Corporation plc
Via GlobeNewswire
Reconstituted Amarin Board Ready for the Challenge of Unlocking True Potential of VASCEPA®/VAZKEPA® (Icosapent Ethyl)
From Amarin Corporation plc
Via GlobeNewswire
Amarin Announces Board Departures
From Amarin Corporation plc
Via GlobeNewswire
Amarin Highlights New Evidence of Therapeutic Value of EPA in Reducing Cardiovascular Events in At-Risk Patients Presented at ACC.23/WCC
From Amarin Corporation plc
Via GlobeNewswire
Amarin Posts New Data Showing Benefit of Vascepa In High-Risk Patients With Acute Coronary Syndrome
Via Benzinga
Amarin Announces New REDUCE-IT® Data at ACC.23/WCC Showing Benefit of VASCEPA®/VAZKEPA® (Icosapent Ethyl) in High-Risk Patients with a Recent Acute Coronary Syndrome Event
From Amarin Corporation plc
Via GlobeNewswire
Amarin Reports Fourth Quarter and Full Year 2022 Financial Results and Provides Business Update
From Amarin Corporation plc
Via GlobeNewswire
Sarissa Capital Wins Proxy Contest Against Amarin by Huge Landslide
From Sarissa Capital Management LP
Via Business Wire
Amarin Announces Preliminary Voting Results Following 2023 General Meeting of Shareholders
From Amarin Corporation plc
Via GlobeNewswire
Amarin and CSL Seqirus Announce Exclusive License and Distribution Agreement to Commercialize VAZKEPA® (Icosapent Ethyl) in Australia and New Zealand
From Amarin Corporation plc
Via GlobeNewswire
Amarin Sets the Record Straight on Sarissa’s Latest Misstatements
From Amarin Corporation plc
Via GlobeNewswire
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.